Natures Sunshine Products PE ratio NATR

Share price divided by earnings per share over the last twelve months, since 2012.

Today, Oct 23, 2026: 12.0×
10-year median: 20.6×
Against its 10-year history: 6th; percentile: 0 is its lowest day, 100 its highest
10-year range: 9.7× to 488×
Peer median: 10.3×

Natures Sunshine Products' PE ratio is 12.0× as of Oct 23, 2026: a share price of $12.15 against $1.01 of earnings per share over the last twelve months.

That is below its ten-year median of 20.6×, lower than on 94% of days in the last ten years.

Over that time it ranged from 9.7× in Jul 2022 to 488× in May 2019.

The median for 10 large drugmakers of a similar size is 10.3×.

PE ratio over time

median 20.6×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	12.0×	12.0×	34.2×
2025	26.7×	15.5×	32.5×
2024	17.1×	15.8×	44.5×
2023	42.2×	15.6×	82.6×
2022	15.4×	9.7×	17.8×
2021	17.6×	12.6×	21.7×
2020	18.0×	14.0×	70.5×
2019	59.1×	50.6×	488×
2018	n/m a value too high to mean anything
2017	103×	15.0×	116×
2016	22.7×	11.6×	27.6×
2015	26.6×	12.8×	44.6×
2014	15.5×	9.9×	15.9×
2013	14.0×	8.0×	15.4×
2012	7.8×	7.8×	14.5×

Against its peers

Companies in Drug Manufacturers - General nearest Natures Sunshine Products' size, closest first, today.

Company	PE ratio
NATRNatures Sunshine Products	12.0×
ARVNArvinas	45.6×
PBYIPuma Biotechnology	21.2×
IRWDIronwood Pharmaceuticals	4.5×
ZVRAZevra Therapeutics	10.5×
CRMDCorMedix	3.7×
LFVNLifevantage	14.7×
SPROSpero Therapeutics	10.1×
COLLCollegium Pharmaceutical	18.5×
ABUSArbutus Biopharma	5.4×
ATNMActinium Pharmaceuticals	4.2×
Peer median	10.3×

Where Natures Sunshine Products ranks

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Natures Sunshine Products

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.